SUVP.F Stock Overview
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services in the United States and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Sartorius Aktiengesellschaft Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €368.00 |
| 52 Week High | €458.32 |
| 52 Week Low | €223.00 |
| Beta | 0.84 |
| 1 Month Change | -7.77% |
| 3 Month Change | n/a |
| 1 Year Change | -19.71% |
| 3 Year Change | -30.57% |
| 5 Year Change | 122.45% |
| Change since IPO | 933.71% |
Recent News & Updates
Recent updates
Shareholder Returns
| SUVP.F | US Life Sciences | US Market | |
|---|---|---|---|
| 7D | -1.9% | -0.2% | -0.9% |
| 1Y | -19.7% | -0.7% | 25.0% |
Return vs Industry: SUVP.F underperformed the US Life Sciences industry which returned -0.7% over the past year.
Return vs Market: SUVP.F underperformed the US Market which returned 25% over the past year.
Price Volatility
| SUVP.F volatility | |
|---|---|
| SUVP.F Average Weekly Movement | n/a |
| Life Sciences Industry Average Movement | 7.1% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: SUVP.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine SUVP.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1870 | 14,614 | Joachim Kreuzburg | www.sartorius.com |
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services in the United States and internationally. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors, and software apps for bioreactors and cell culture shake flask; fermenters; cell culture media products; cellcelector flex, incubator flowbox, nanowell arrays, and capillaries and tips; fluid management products; microbiology products; and Ultrafiltration membrane filters, glass and quartz microfiber filters, clarification, syringeless and in-line filters, lab chromatography, and filters and blotting papers. It also provides live-cell analysis systems, reagents and consumables, support and services, and live-cell imaging and analysis software; contract manufacturing and integration, membranes and devices, weigh cells, and data analytics, as well as connectivity, and pipetting and dispensing modules; electronic and mechanical pipettes, pipette tips, bottle-top dispensers, and pipette controllers and accessories; process automation platform and software, sensors and analyzers, biomolecule analysis tools, and data analytics software; chromatography consumables, columns, and systems; and biolayer interferometry products.
Sartorius Aktiengesellschaft Fundamentals Summary
| SUVP.F fundamental statistics | |
|---|---|
| Market cap | US$22.59b |
| Earnings (TTM) | US$219.94m |
| Revenue (TTM) | US$3.64b |
114.4x
P/E Ratio6.9x
P/S RatioIs SUVP.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SUVP.F income statement (TTM) | |
|---|---|
| Revenue | €3.40b |
| Cost of Revenue | €1.83b |
| Gross Profit | €1.57b |
| Other Expenses | €1.36b |
| Earnings | €205.20m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 18, 2024
| Earnings per share (EPS) | 2.97 |
| Gross Margin | 46.15% |
| Net Profit Margin | 6.04% |
| Debt/Equity Ratio | 187.3% |
How did SUVP.F perform over the long term?
See historical performance and comparison